"Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support." by Angeline N Beltsos

Selected Works of Mark Sanchez, MD, FACOG

Article

Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support.

Reproductive Health (2014)

Angeline N Beltsos, Fertility Centers of Illinois, River North Center, Chicago, USA
Mark D Sanchez, Women’s Medical Research Group, LLC, Florida Fertility Institute, Clearwater, USA
Kevin J Doody, The Center for Assisted Reproduction, Bedford, USA
Mark R Bush, Conceptions Reproductive Associates of Colorado, Littleton, USA
Alice D Domar, Domar Center for Mind/Body Health, Waltham, USA
Michael G Collins, Ferring Pharmaceuticals

Link

Disciplines

Publication Date

November 11, 2014

DOI

10.1186/1742-4755-11-78

Citation Information

Angeline N Beltsos, Mark D Sanchez, Kevin J Doody, Mark R Bush, et al.. "Patients' administration preferences: progesterone vaginal insert (Endometrin®) compared to intramuscular progesterone for Luteal phase support." Reproductive Health Vol. 11 Iss. 1 (2014) p. 78 - 78
Available at: http://works.bepress.com/mark-sanchez/1/